HeartBeam, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $27.1M
- Price
- $0.4801
- % Change (Daily % change from the live per-ticker quote feed.)
- -3.98%
- Volume
- 412.3K
About
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Quick stats
Shares outstanding56.3M
Computed float41.3M
Float / shares73.3%
Cash runway (months)-2.7
Key info
SectorHealthcare
IndustryMedical - Specialties
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001779372
Websitehttps://www.heartbeam.com
AI Summary
AI-generated1/33
standardbullishearnings
HeartBeam Reports Second Quarter 2026 Results
HeartBeam reported second quarter 2026 results with a net loss of $5.0 million, or $0.10 per share, while highlighting the start of its commercial launch and ahead-of-schedule progress in clinical trials.
The company strengthened its balance sheet to $8.7 million in cash following an April offering and reduced its net operating cash outflow guidance to below $14.0 million for the full year.
Operational milestones included completing enrollment in the ALIGN-ACS pilot study and shipping first orders for the HeartBeam System in four targeted U.S. geographies.
Red flags
- SG&A expenses increased due to severance and equity acceleration costs for former CEO